Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anteris Technologies Global Corp. Capital/Financing Update 2010

Mar 16, 2010

33869_rns_2010-03-16_0d344051-cb61-482a-89c3-7d85124647be.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [596 x 64] intentionally omitted <==

Innovative BioMedical Devices

Level 11, 225 St Georges Terrace Telephone (08) 9262 6777 bioMD Limited ABN 35 088 221 078 Facsimile (08) 9322 3433 Perth, Western Australia 6000 PO Box 7209, Cloisters Square www.biomd.com.au Western Australia 6850

ANNOUNCEMENT TO THE AUSTRALIAN STOCK EXCHANGE

1 of 1 page

17 March 2010

Company Announcements Office Australian Securities Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

Entitlements Issue Offer Document Despatch

The Directors of the Company wish to announce the despatch today to shareholders of its Entitlements Issue Offer Document for its non-renounceable rights issue to raise approximately $1.3 million.

The Entitlements Issue Offer Document was lodged with ASIC and ASX Limited on 25 February 2010.

Further information can be obtained from:

Robert Towner, Executive Director bioMD Limited Ph: 08 9262 6777 E: [email protected]

Yours faithfully

==> picture [78 x 59] intentionally omitted <==

Caroline Bentley Company Secretary

==> picture [596 x 41] intentionally omitted <==